IBS-D is a subtype of irritable bowel syndrome where diarrhea is the dominant bowel pattern. It accounts for roughly 26.5% of all IBS cases, making it one of the most common forms alongside IBS with constipation and IBS with mixed bowel habits. The hallmark is frequent loose or watery stools, often accompanied by abdominal pain and urgency that can strike with little warning.
How IBS-D Is Defined
Irritable bowel syndrome is classified into subtypes based on what your stool typically looks like, using a visual guide called the Bristol Stool Scale. If more than 25% of your bowel movements are loose or watery (types 6 and 7 on that scale), and fewer than 25% are hard or lumpy, you fall into the diarrhea-predominant category. The diagnosis requires recurrent abdominal pain at least one day per week, on average, over the previous three months, with symptom onset at least six months before diagnosis.
The other subtypes are IBS-C (constipation-predominant), IBS-M (mixed, alternating between diarrhea and constipation), and IBS-U (unclassified, where stool patterns don’t fit neatly into the other groups). Your subtype can shift over time, and many people move between categories throughout their lives.
What IBS-D Feels Like Day to Day
The defining experience is urgency. Many people with IBS-D describe needing a bathroom immediately after eating, sometimes before they’ve finished a meal. Stools are loose, sometimes watery, and may come in clusters of several trips to the bathroom within a short window. Cramping abdominal pain typically accompanies or precedes a bowel movement and often improves afterward, at least temporarily.
Bloating and gas are common. Some people notice mucus in their stool. Unlike conditions such as inflammatory bowel disease or microscopic colitis, IBS-D does not typically cause nighttime diarrhea that wakes you from sleep, bloody stool, or unexplained weight loss. Those symptoms point toward something else and warrant further investigation.
What’s Happening Inside the Gut
IBS-D involves a combination of problems in how the gut moves, senses, and communicates with the brain. The colon moves its contents through faster than normal, which means less water gets absorbed and stools come out loose. At the same time, the nerves lining the gut are hypersensitive, so normal amounts of gas or stretching that wouldn’t bother most people register as pain or discomfort.
The gut and brain are in constant two-way communication through what’s often called the gut-brain axis. In IBS-D, this signaling system is turned up. Stress, anxiety, and emotional states amplify gut sensations, while gut distress feeds back into mood and anxiety. This isn’t “all in your head,” but it does explain why psychological stress so reliably triggers flare-ups.
Research has also found that people with IBS-D tend to have an imbalanced gut microbiome. Studies show higher levels of certain bacterial groups and lower levels of others compared to healthy controls. Whether this imbalance is a cause or a consequence of the condition isn’t fully settled, but it helps explain why some treatments targeting gut bacteria can provide relief.
Conditions That Mimic IBS-D
One of the most important things to know about IBS-D is that other treatable conditions can look nearly identical. Getting the right diagnosis matters because the treatments are different.
Bile acid malabsorption is the biggest overlap. Somewhere between 25% and 50% of people diagnosed with IBS-D actually have excess bile acids reaching the colon, which triggers watery diarrhea. A systematic review found that about 32% of patients with IBS-D symptoms had evidence of bile acid diarrhea. This is significant because bile acid diarrhea responds well to bile acid binders, a treatment that wouldn’t typically be tried under a standard IBS-D diagnosis. If your diarrhea is particularly watery and happens soon after meals, it’s worth asking about testing for this.
Microscopic colitis is another condition frequently mistaken for IBS-D. The colon looks normal during a standard colonoscopy, so diagnosis requires taking tissue samples and examining them under a microscope. Key differences can help distinguish the two: nighttime diarrhea occurred in about 73% of microscopic colitis patients compared to just 10% of IBS-D patients in one study. Mild weight loss and elevated stool inflammation markers were also far more common in microscopic colitis. The pattern in IBS-D, by contrast, leans more toward abdominal pain and bloating as prominent features.
Celiac disease, infections, and thyroid disorders can also produce chronic diarrhea and are typically ruled out with blood tests and stool samples before an IBS-D diagnosis is made.
Dietary Approaches
Diet is usually the first thing people try, and for good reason. The low FODMAP diet, which temporarily removes certain fermentable carbohydrates found in foods like onions, garlic, wheat, certain fruits, and dairy, has the strongest evidence. In one study, over 90% of IBS patients reported symptom reduction after following it, with bloating showing the greatest improvement. Research has found particularly strong results in IBS-D specifically.
The low FODMAP diet works in three phases: a strict elimination period (usually two to six weeks), a reintroduction phase where you test individual food groups one at a time, and a personalization phase where you settle into a long-term pattern that avoids only your specific triggers. Working with a dietitian familiar with the protocol makes a meaningful difference in success rates, because the elimination phase is restrictive and nutritionally incomplete if followed indefinitely.
Soluble fiber supplementation, around 20 to 30 grams per day of psyllium or a similar source, is recommended as a first-line measure for IBS overall. For IBS-D specifically, this might seem counterintuitive, but soluble fiber absorbs excess water in the colon and can actually firm up loose stools. Insoluble fiber (bran, raw vegetables) tends to make things worse.
Medications for IBS-D
Several prescription options exist when diet changes aren’t enough. A short-course antibiotic that stays in the gut without being absorbed into the bloodstream is FDA-approved for IBS-D and works by rebalancing gut bacteria. Its effectiveness has been confirmed across multiple controlled trials. Despite the evidence, surveys show that only about 4.5% of IBS-D patients had used it, suggesting it’s underutilized, particularly by primary care doctors compared to gastroenterologists.
Another FDA-approved option works by slowing gut contractions and reducing fluid secretion in the intestine. A third, approved specifically for women with severe IBS-D who haven’t responded to other treatments, targets receptors that control both pain signaling and gut motility. Satisfaction rates for these prescription medications hover around 20% to 34%, which reflects the reality that IBS-D responds differently in different people, and finding the right approach often takes trial and adjustment.
Over-the-counter anti-diarrheal medications can help manage acute episodes but aren’t intended as a long-term solution on their own.
Brain-Gut Therapies
Because of the strong gut-brain connection driving IBS-D, psychological therapies have become a mainstream part of treatment, not an afterthought. Both cognitive behavioral therapy and gut-directed hypnotherapy have strong evidence for short-term and long-term symptom improvement in controlled trials. Both are now recommended by European and North American gastroenterology guidelines as treatment options.
Gut-directed hypnotherapy involves a trained therapist guiding you through relaxation and visualization exercises focused on normalizing gut function. Sessions typically happen weekly over 8 to 12 weeks. It sounds unconventional, but the clinical data is robust enough that major gastroenterology organizations endorse it. CBT for IBS focuses on breaking the cycle between catastrophic thinking about symptoms, avoidance behaviors (like not eating before leaving the house), and the physiological stress response that worsens gut symptoms. Both approaches aim to recalibrate the overactive communication loop between brain and gut.
Why Subtyping Matters for Treatment
The reason IBS is split into subtypes at all is that treatments differ sharply depending on your predominant pattern. Medications that help IBS-D would make IBS-C worse, and vice versa. Dietary triggers also vary by subtype. Even within IBS-D, the underlying driver can differ from person to person. Someone whose symptoms stem primarily from bile acid issues, for example, will respond to a completely different treatment than someone whose main problem is gut-brain hypersensitivity or microbiome disruption.
This is why many people cycle through several approaches before finding what works. A combination strategy, pairing dietary changes with either medication or brain-gut therapy, tends to produce better results than any single intervention alone.